• SENSEX 72,480.29
    -48.78 (--0.07%)
  • BANKNIFTY 54,633.05
    373.10 (+0.69%)
  • Avalon Tech
    2,171.00 778.15(%)
  • Bharti Airtel
    1,753.30 1,745.00(%)
  • NSE
    1,761.00 1,761.00(%)
  • Molbio Diagnosti
    1,368.00 1,686.50(%)
  • Apollo Hospitals
    8,063.00 6,680.00(%)
  • Innova Captab
    1,080.00 608.25(%)
  • Hero Motors
    152.58 156.03(%)
  • Meesho
    230.55 254.65(%)
  • Azad Engineering
    3,126.00 3,126.00(%)
  • Shadowfax Technologies
    278.10 98.60(%)
  • Cupid
    312.10 312.10(%)
  • L&T Finance Ltd
    264.75 234.90(%)
  • Lenskart Solut.
    698.00 725.00(%)
  • Reliance Industries
    1,196.30 1,611.20(%)
  • SS Retail
    761.45 888.00(%)
  • Sun TV Network
    664.60 664.60(%)
  • Solar Industries
    19,820.00 22,630.05(%)
  • PB Fintech.
    1,040.00 1,040.00(%)
  • National High
    168.00 142.00(%)
  • HDFC Bank
    709.70 682.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Chandra Bhagat Pharma Ltd Trading

  • Indian Private
  • BSE Code : 74652.0
  • ISIN : INE07QQ01016
49.40 0 (-0.10%)
  • As on 30 Sep 2026 (EOD)

  • Today’s Low

    49.40

  • Today’s High

    49.40

  • Open

    49.40

  • Perv Close

    49.45

  • 52W Low

    29.70

  • 52W High

    52.99

Key Indicators

  • P/E(TTM)

    12.23

  • Mar.Cap (₹Cr.)

    37.27

  • Div & Yield %

    0.00

  • Book Value(₹)

    43.90

  • Debt-Equity Ratio

    -0.10

  • AGM Date

    28-Sep-2026

  • EPS

    4.04

  • P/E Ratio

    12.23

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    37.27

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    7.55

  • BV (₹)

    43.90

  • Sales( ₹ in Cr.)

    116.27

  • NP (in Cr.)

    3.05

  • NP Var(%)

    331.0

  • Div%

    0.0

  • CPS (₹)

    5.50

  • EPS (₹)

    4.00

  • Traded Value (₹ in Lakhs)

    37.27

  • 52 Week High

    52.99

  • 52 Week Low

    29.70

  • Price BSE

    49.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    37.27

  • P/C Ratio

    8.90

  • P/E Ratio

    12.10

  • Price Vs.BV

    4.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 116.27 88.81 221.37 119.67 94.08 70.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 116.27 88.81 221.37 119.67 94.08 70.70
Other Income 3.35 3.43 11.33 0.29 1.62 0.48
Stock Adjustments 3.42 -7.98 1.02 -2.01 0.08 -5.96
Total Income 123.04 84.26 233.72 117.95 95.78 65.22
EXPENDITURE :            
Raw Materials 96.98 65.30 209.06 104.57 81.44 53.78
Power and Fuel Cost 0.13 0.10 0.09 0.07 0.07 0.05
Employee Cost 2.53 2.03 2.18 1.32 1.52 1.85
Other Manufacturing Expenses 0.13 0.34 0.36 0.27 0.24 0.12
Selling and Administration Expenses 14.67 12.42 17.75 7.30 5.45 4.85
Miscellaneous Expenses 1.39 0.01 0.00 0.80 2.61 0.41
Employee Benefit Expenses 2.53 2.03 2.18 1.32 1.52 1.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 115.84 80.19 229.44 114.33 91.32 61.05
Operating Profit 7.20 4.07 4.29 3.63 4.46 4.16
Interest 2.00 1.95 1.39 2.20 3.24 3.76
Gross Profit 5.20 2.12 2.90 1.43 1.22 0.40
Depreciation 1.10 0.95 0.64 0.27 0.12 0.12
Profit Before Tax 4.10 1.17 2.26 1.16 1.10 0.28
Current Tax 1.16 0.36 0.77 0.25 0.30 0.08
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.10 -0.05 -0.03 0.00 0.00 0.01
Reported Net Profit 3.05 0.86 1.53 0.91 0.80 0.19
Extraordinary Items 0.00 0.15 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.05 0.71 1.53 0.91 0.80 0.19
Adjustment below Net Profit 0.11 0.10 0.00 -0.10 0.00 0.00
P & L Balance brought forward 9.05 8.09 6.56 5.76 4.96 4.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 12.21 9.05 8.09 6.56 5.76 4.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 4.04 1.14 2.03 1.20 1.06 0.25
Earnings Per Share(Adj)-Unit Curr 4.04 1.14 2.03 1.20 1.06 0.25
Book Value 43.90 39.72 38.45 36.42 35.35 34.30
Book Value(Adj)-Unit Curr 43.90 39.72 38.45 36.42 35.35 34.30

Shareholding Pattern

  • Promoter Group

    73.02%

  • Public Share Holding

    26.98%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,509,056 73.02 5,509,056 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,509,056 73.02 5,509,056 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 909,000 12.05 909,000 9
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 95,000 1.26 95,000 9
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 172,000 2.28 172,000 15
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 282,000 3.74 282,000 5
Individuals holding nominal share capital up to Rs. 1 lakh 573,000 7.59 573,000 231
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,036,000 26.98 2,036,000 270
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 7,545,056 100.00 7,545,056 280

Company Background

Chandra Bhagat Pharma LtdTrading

  • Chandra Bhagat Pharma Ltd
  • BSE Code : 74652.0
  • ISIN : INE07QQ01016

  • Incorporation Year

    2003

  • Registered Office

    323-F Bhagat Bhuvan
    Dr Ambedkar Road Matunga (E), Mumbai,
    Maharashtra-400019

  • Telephone

    91-22-24146154

  • FAX

  • Chairman

    Hemant C Bhagat

  • Managing Director

  • Company Secretary

    Rajni Dawani

  • Auditor

    A Y & Company

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Chandra Bhagat Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Chandra Bhagat 49.40 119.63 116.27 12.23 12.16
Abbott India 27,149.40 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,188.75 2,304.07 2,275.58 91.21 27.86
Glaxosmi. Pharma 2,767.60 3,932.76 3,790.20 44.21 58.17
Novartis India 1,923.85 393.10 354.33 48.58 15.94
Cipla 1,350.00 20,102.60 18,979.95 35.48 13.88
Bliss GVS Pharma 695.35 773.53 729.81 64.62 12.51
Fermenta Biotec. 549.65 474.15 450.25 25.66 18.77
Amrutanjan Healt 514.30 520.13 502.55 27.55 24.16
Guj. Themis Bio. 387.75 168.25 165.82 103.68 18.05
Ambalal Sarabhai 39.51 19.52 3.94 73.17 6.77